Single Use Cystoscope Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2024-2031- (By Derivatives Coverage, Geographic Coverage and By Company)

The global single-use cystoscope market is set for robust growth over the forecast period of 2024 to 2031. According to a recent report by the publisher, the market, which is expected to generate US$ 90.81 Million in revenue in 2024, will grow at a compound annual growth rate (CAGR) of 9.1%, reaching a valuation of approximately US$ 167 Million by 2031. The rise in demand for improved diagnostics and treatments for urinary tract problems is driving this market expansion.

Market Insights

• Revenue Outlook: The single-use cystoscope market, accounting for about 0.25% of the total global urology device market (valued at US$ 30.4 Billion in 2023), is expected to see increasing demand due to its effective solutions for urinary tract diagnostics and treatment. Flexible video single-use cystoscopes are projected to hold the largest market share, estimated at 86.6% in 2024.
• Technological Advantage: Single-use cystoscopes provide consistency in quality, minimize risks of cross-contamination, and eliminate the need for time-consuming reprocessing and repairs associated with reusable devices. This efficiency and safety are key factors propelling their market adoption, particularly for diagnosing urinary tract infections (UTIs), bladder cancer, and other related conditions.

Drivers of Market Growth

1. Increasing Urological Problems:

Single-use cystoscopes play a critical role in the diagnosis and treatment of urinary tract infections (UTIs), bladder cancers, urethral blockages, and other urological conditions. Growing incidences of these conditions, especially in the elderly, are fueling the demand for these devices.

2. Geriatric Population and UTIs:

As per a 2021 study in Frontiers in Public Health, UTIs are common among the elderly and are a significant cause of hospitalizations. With approximately 7 million hospital visits related to UTIs each year, the need for more accurate and efficient diagnostic tools like single-use cystoscopes continues to rise.

3. Rising Cancer Diagnoses:

According to WHO data, prostate cancer cases worldwide reached 1.41 million in 2020, while bladder cancer cases numbered 600,000. Early detection is crucial for successful treatment, and single-use cystoscopes provide the clarity and reliability needed for precise diagnosis.

Business Opportunities

1. New Product Development and Partnerships:

Key players in the market are focusing on launching innovative products and forming strategic partnerships to offer high-quality, cost-effective, and disposable endoscopic products. This is enhancing product availability and driving competition in the market.

2. Region-Specific Market Expansion:

The U.S. market, holding 33.7% of the global market share in 2023, is experiencing significant growth due to the prevalence of recurrent UTIs, especially in women. In the U.K., the high incidence of bladder cancer and associated healthcare costs are driving demand for early detection tools like cystoscopes. In India, the demand is fueled by poor sanitation and the rising prevalence of UTIs.

Region-wise Market Insights

1. United States:

The U.S. market is thriving due to the high occurrence of recurrent UTIs, especially among women. Cystoscopy is increasingly being used to identify curable causes of these infections.

• Approximately 50% of women experience at least one symptomatic UTI in their lifetime, with a 26% chance of recurrence.
• Cystoscopy is helping detect urinary tract blockages and small tumors early, boosting the adoption of single-use devices.

2. United Kingdom:

With an estimated 10,300 new bladder cancer cases annually, the U.K. is experiencing growing demand for single-use cystoscopes for early cancer detection. The high recurrence rate of bladder cancer and its associated healthcare costs have made cystoscopies a critical tool in managing the disease.

3. India:

Inadequate sanitation facilities and unhygienic toilet practices are contributing to an increase in UTIs, especially among women. A cross-sectional study conducted in Indian slums revealed a UTI prevalence of 19.6% among women aged 18 to 60. This is driving the need for more efficient diagnostic tools like single-use cystoscopes.

Challenges to Market Growth

1. Skilled Professional Shortage:

Single-use cystoscopes require skilled professionals for effective usage. The limited availability of highly trained personnel in some regions may hinder market expansion.

2. Product Availability:

Currently, only a few players offer single-use cystoscopes, limiting options for buyers. In addition, many healthcare facilities have already invested in reusable devices, which may slow the adoption of single-use alternatives.

3. Post-procedure Side Effects:

Although single-use cystoscopes offer significant advantages, minor side effects such as burning during urination, frequent urination, or mild discomfort may affect their overall adoption rate.

Key Players in the Market

Leading companies in the global single-use cystoscope market include:

• Coloplast Group
• NeoScope Inc.
• Asieris Pharmaceuticals
• Stryker
• Ambu
• Olympus Medical Corporation
• PENTAX Medical
• Richard Wolf GmBH
• Cogentix Medical
• Karl Storz
• Henke-Sass Wolf
• Advanced Health Care Resources
• UroViu Corporation

Single-use Cystoscope Market Segmentation

Product

• Flexible Single-use Cystoscope
• Semi-Flexible Single-use Cystoscope

End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

Region

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa (MEA)

This product will be delivered within 1-3 business days.